HCA Healthcare reported revenue of $14.97bn in Q3 2022, a decline of 1.98% as against $15.27bn in the corresponding period of 2021.

Net income attributable to the company stood at $1.13bn, or $3.91 per diluted share in third quarter of 2022, a decline of 66.66% as against $2.26bn, or $7.00 per diluted share, in the third quarter of last year.

Results for Q3 2022 include losses on sales of facilities of $3m, while results for Q3 2021 included gains on sales of facilities of $1.04bn, associated to the sale of four hospitals in Georgia and other health care entity investments.

In the third quarter of 2022, adjusted EBITDA totalled $2.90bn, as against $3.2bn in Q3 2021.

Same facility admissions fell 1.5% in Q3 2022, while same facility equivalent admissions grew 2.3% in Q3 2022, compared with the corresponding period of the prior year. Same facility emergency room visits fell 1.3% in Q3 2022, compared with the prior year period, while same facility inpatient surgeries grew 5.6%, and same facility outpatient surgeries rose 2% in the third quarter of 2022, as against the same period of 2021.

The company reported that the same facility revenue per equivalent admission fell 3.5% in Q3 2022, compared with the same period of 2021.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Year over year comparisons were affected by significantly higher Covid-19 volumes in the prior year, when Covid-19 represented 12.7% of same-facility admissions as against 5.2% in the present year quarter.

Revenue for the nine months touched $44.73bn, an increase of 2.37% as against $43.68bn in the same period of 2021.

Net income attributable to the company was $3.56bn, or $11.97 per diluted share, an increase of 36.32% as against $5.14bn, or $15.43 per diluted share, for the first nine months of 2021.

Results for the nine months of 2022 include losses on sales of facilities of $25m, and losses on retirement of debt of $78m.

As of 30 September 2022, HCA Healthcare operated 182 hospitals and around 2,300 ambulatory sites of care in 20 US states and the UK.